Back    Zoom +    Zoom -
JD HEALTH Deepens Cooperation with Haleon
Recommend
8
Positive
10
Negative
4
JD HEALTH (06618.HK) announced a deeper collaboration with multinational consumer health company, Haleon.

The two parties will comprehensively build a new health service ecosystem for holistic disease co-management and co-governance, driving innovation from chronic disease management to full-cycle health management models.

Related NewsKaiyuan Securities Anticipates Alibaba's Qianwen to Use Agents to Call Fliggy/ Taobao APIs, Merging Models & E-commerce into One
This year, the collaboration will expand to over 15 disease and health domains including pediatric growth and development, respiratory system and mental health.

Haleon was spun off and listed from GSK (GSK.US) in 2022, owning consumer health brands such as Panadol, Sensodyne, Polident, Otrivin and Centrum.
AASTOCKS Financial News
Website: www.aastocks.com